Voltage-Gated Sodium Channels: New Targets in Cancer Therapy?

Author(s): Sebastien Roger, Marie Potier, Christophe Vandier, Pierre Besson, Jean-Yves Le Guennec

Journal Name: Current Pharmaceutical Design

Volume 12 , Issue 28 , 2006

Become EABM
Become Reviewer
Call for Editor


Early detection and treatment of cancers have increased survival and improved clinical outcome. The development of metastases is often associated with a poor prognostic of survival. Finding early markers of metastasis and developing new therapies against their development is a great challenge. Since a few years, there is more evidence that ionic channels are involved in the oncogenic process. Among these, voltage-gated sodium channels expressed in non-nervous or non-muscular organs are often associated with the metastatic behaviour of different cancers. The aim of this review is to describe the current knowledge on the functional expression of voltage-gated sodium channels and their biological roles in different cancers such as prostate, breast, lung (small cells and non-small cells) and leukaemia. In the conclusion, we develop conceptual approaches to understand how such channels can be involved in the metastatic process and conclude that blockers targeted toward these channels are promising new therapeutic solutions against metastatic cancers.

Keywords: Cancers, voltage-gated sodium channels, TTX, metastasis, invasivity, motility, galvanotaxis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [3681 - 3695]
Pages: 15
DOI: 10.2174/138161206778522047
Price: $65

Article Metrics

PDF: 12